Di-Methyl-Histone H2B (Lys43) Antibody

What is Di-Methyl-Histone H2B (Lys43) Antibody and what does it specifically detect?

The Di-Methyl-Histone H2B (Lys43) Antibody is a polyclonal antibody produced in rabbits that specifically recognizes the di-methylated form of histone H2B at lysine 43 (H2BK43me2). This antibody binds with high specificity to this particular post-translational modification, enabling researchers to detect and study this epigenetic mark across various experimental platforms . The antibody is designed to recognize endogenous levels of di-methylated H2B at lysine 43, a modification associated with gene regulation and chromatin structure dynamics . Most commercial versions of this antibody are affinity-purified using a synthetic di-methylated peptide corresponding to residues surrounding Lys43 of human histone H2B, ensuring high specificity to the intended target . This targeted approach makes the antibody particularly valuable for epigenetic research focusing on specific histone modifications rather than total histone levels.

The di-methylation of histone H2B at lysine 43 represents an important epigenetic mark within the complex language of the histone code. Unlike better-studied modifications such as H3K79 methylation or H2B ubiquitylation, the specific role of H2BK43 di-methylation is still being elucidated in current research, making this antibody an important tool for expanding our understanding of chromatin regulation . The antibody enables detection of this modification across multiple species including human, mouse, and rat samples due to the high conservation of histone proteins across mammalian species . Researchers should note that while the antibody has high specificity for the di-methylated form, cross-reactivity with mono- or tri-methylated forms should be considered when interpreting experimental results.

What applications is the Di-Methyl-Histone H2B (Lys43) Antibody suitable for?

The Di-Methyl-Histone H2B (Lys43) Antibody is suitable for multiple experimental applications in epigenetic and chromatin research. Western blotting (WB) represents one of the primary applications, with recommended dilutions typically ranging from 1:500 to 1:1000 depending on the specific antibody preparation and experimental conditions . This application allows researchers to detect and quantify the presence of H2BK43me2 in cellular or tissue lysates, providing insights into the levels of this modification under various experimental conditions or disease states. The antibody is also suitable for enzyme-linked immunosorbent assay (ELISA), enabling quantitative measurement of this histone modification in purified samples .

Beyond these basic applications, the Di-Methyl-Histone H2B (Lys43) Antibody can be utilized in chromatin immunoprecipitation (ChIP) assays to identify genomic regions associated with this specific histone modification . This approach allows researchers to map the distribution of H2BK43me2 across the genome and correlate it with gene expression patterns or other epigenetic marks. Immunofluorescence represents another valuable application, enabling visualization of this modification within the nuclear architecture and its potential co-localization with other nuclear components or modifications . For researchers interested in the dynamics of this modification, the antibody can be employed in time-course experiments following treatment with epigenetic modulators, providing insights into the establishment, maintenance, and removal of this mark. When designing experiments, researchers should consider appropriate controls including peptide competition assays to confirm specificity, particularly in novel experimental systems.

What is the significance of H2B lysine 43 di-methylation in epigenetic regulation?

Histone H2B lysine 43 di-methylation represents an important but still emerging area in epigenetic research. While extensively studied histone modifications like H3K79 methylation and H2B ubiquitylation have well-established roles in transcriptional regulation, the specific function of H2BK43me2 is still being fully characterized . Current research suggests that this modification, like other histone methylation marks, likely participates in the complex regulatory mechanisms controlling gene expression, chromatin structure, and cellular identity. The position of lysine 43 within the H2B protein structure places it in a region that may influence nucleosome stability and higher-order chromatin organization, potentially affecting accessibility of DNA to transcription factors and other regulatory proteins .

Understanding H2BK43 di-methylation requires considering it within the broader context of histone modifications and their interplay. Research on related histone modifications suggests that H2BK43me2 may participate in trans-histone pathways, where modifications on one histone influence modifications on another, creating a complex regulatory network . For example, studies on other H2B modifications like ubiquitylation have demonstrated their influence on H3K79 methylation through such trans-histone mechanisms . The enzymes responsible for writing and erasing H2BK43me2 (methyltransferases and demethylases, respectively) represent important areas of ongoing research, as these enzymes often serve as potential therapeutic targets in diseases with epigenetic dysregulation. The presence or absence of H2BK43me2 may also serve as a biomarker for specific cellular states or disease conditions, similar to other histone modifications that have proven valuable in cancer research and other fields.

How does H2BK43 di-methylation interact with other histone modifications in the histone code?

The interplay between H2BK43 di-methylation and other histone modifications represents a complex aspect of the histone code that is still being fully elucidated. Current research on histone modifications has established numerous examples of cross-talk between different marks, suggesting that H2BK43me2 likely functions within a broader network of modifications rather than in isolation . One particularly relevant comparison is with H2B ubiquitylation at lysine 120 (H2BK120ub), which has been extensively studied and shown to influence H3K79 methylation through trans-histone pathways . Based on studies of other histone methylation marks, H2BK43me2 may similarly participate in regulatory circuits that include modifications on other histones, potentially creating feedback loops or sequential modification patterns that collectively determine chromatin states and gene expression outcomes.

The spatial relationship between H2BK43 and other modified residues within the nucleosome structure provides important clues about potential functional interactions. Structural studies of the nucleosome have revealed that certain histone residues are positioned in close proximity despite residing on different histone proteins, enabling direct interaction or cooperative effects . For example, H2B lysine residues can be positioned near H3K79, facilitating the trans-histone regulation observed between H2B ubiquitylation and H3K79 methylation . Research has shown that modifications of charged amino acids in histone tails, such as those in the H4 N-terminal tail, can regulate the activity of histone-modifying enzymes like Dot1, which methylates H3K79 . This suggests that similar mechanisms might exist for regulation of enzymes that modify H2BK43, potentially creating complex regulatory networks. Understanding these interactions requires integrative approaches combining structural biology, biochemistry, and genomics to map the complete modification landscape and its dynamic changes during cellular processes.

What are the technical considerations for using Di-Methyl-Histone H2B (Lys43) Antibody in ChIP assays?

Chromatin immunoprecipitation (ChIP) using Di-Methyl-Histone H2B (Lys43) Antibody requires careful optimization to ensure specific and reproducible results. The first critical consideration is fixation conditions, as over-fixation can mask epitopes while under-fixation may not adequately preserve protein-DNA interactions . For histone modifications like H2BK43me2, a standard starting point is 1% formaldehyde for 10 minutes at room temperature, but this should be optimized for each experimental system. Sonication conditions must be carefully calibrated to generate chromatin fragments of appropriate size (typically 200-500 bp) without causing excessive heat that might affect epitope integrity or antibody recognition. Researchers should verify sonication efficiency through agarose gel electrophoresis before proceeding with immunoprecipitation steps.

Antibody amount and incubation conditions represent another critical parameter requiring optimization. A typical starting point is 2-5 μg of Di-Methyl-Histone H2B (Lys43) Antibody per ChIP reaction, but this should be titrated to determine the optimal concentration for maximum signal-to-noise ratio . Including appropriate controls is essential: an IgG control from the same species as the primary antibody serves as a negative control for non-specific binding, while a ChIP with an antibody against total H2B or a well-characterized histone modification provides a positive control. When analyzing ChIP data, researchers should normalize to input DNA and consider the distribution pattern of H2BK43me2 relative to genomic features like transcription start sites, enhancers, or repressed chromatin regions.

For researchers combining ChIP with high-throughput sequencing (ChIP-seq), additional considerations include sequencing depth (typically 20-30 million reads for histone modifications), peak calling algorithms appropriate for broadly distributed histone marks rather than sharply defined transcription factor binding sites, and bioinformatic pipelines that can integrate H2BK43me2 data with other epigenomic datasets. Given that H2BK43me2 remains less characterized than many other histone modifications, researchers might consider parallel ChIP experiments with antibodies against better-studied marks like H3K4me3 or H3K27me3 to provide contextual information for interpreting H2BK43me2 distribution patterns.

How does H2B lysine 43 di-methylation compare functionally with H2B ubiquitylation?

The functional comparison between H2B lysine 43 di-methylation and H2B ubiquitylation reveals distinct roles in chromatin regulation despite both occurring on the same histone protein. H2B ubiquitylation, particularly at lysine 120 (H2BK120ub), has been extensively characterized and shown to play crucial roles in transcriptional regulation and establishing other histone modifications through trans-histone pathways . Research has demonstrated that H2BK120 ubiquitylation influences H3K79 methylation by regulating the activity of the Dot1/DOT1L methyltransferase, creating a regulatory link between these modifications . In contrast, the specific regulatory networks involving H2BK43 di-methylation are still being elucidated, though its position within the nucleosome suggests it may have distinct functional impacts on chromatin structure.

The physical differences between these modifications are substantial and likely contribute to their distinct functions. Ubiquitin is a large 76-residue protein that, when conjugated to H2B, creates a significant structural perturbation that can alter nucleosome dynamics and stability . Studies using semi-synthetically ubiquitylated H2B have shown that H2BK34 ubiquitylation (near the K43 position) widens the DNA gyre gap in nucleosomes and affects internucleosomal interactions, while H2BK120 ubiquitylation does not significantly impact these properties . In contrast, methylation is a much smaller modification that adds only methyl groups to the lysine residue, suggesting its effects may be more subtle and potentially mediated through altered protein-protein interactions rather than major structural changes to the nucleosome itself.

The regulatory dynamics of these modifications also differ significantly. H2B ubiquitylation is often described as transient and less stable than histone methylation, with only approximately 10% of H2B molecules being ubiquitylated at any given time . This transient nature suggests a dynamic regulatory mechanism that can rapidly respond to cellular signals. The stability and turnover rate of H2BK43 di-methylation remains less characterized but may follow patterns similar to other histone methylation marks, which can be more stable and potentially serve as more persistent epigenetic marks. Understanding the enzymes responsible for writing, reading, and erasing these marks is crucial for determining their distinct roles in chromatin regulation and potential interplay in coordinating gene expression programs.

What is the relationship between H2B modifications and nucleosome structure?

Histone H2B modifications significantly impact nucleosome structure and dynamics, influencing broader chromatin organization and accessibility. Research using single-molecule FRET and other biophysical techniques has demonstrated that specific H2B modifications can alter fundamental nucleosome properties . For example, H2BK34 ubiquitylation (proximal to the K43 position) has been shown to widen the DNA gyre gap in nucleosomes, potentially increasing DNA accessibility to transcription factors and other regulatory proteins . This structural change has functional consequences, as H2BK34 ubiquitylation also facilitates dinucleosome formation and stabilizes dinucleosome stacks, suggesting roles in both local chromatin accessibility and higher-order chromatin organization . These findings provide a mechanistic framework for understanding how H2B modifications might influence transcription and other DNA-templated processes.

The positioning of H2B lysine 43 within the nucleosome structure provides important context for understanding the potential impact of its di-methylation. Crystal structures of nucleosomes have revealed that H2B contributes significantly to the interface with DNA and participates in interactions with other histones within the octamer . The C-terminal helix (αC) of histone H2B serves as an important recognition surface for chromatin-binding proteins, as evidenced by the interaction between DOT1L and this region during H3K79 methylation . The acidic patch formed by H2A-H2B is another critical feature of the nucleosome surface that mediates interactions with numerous chromatin-associated proteins, including DOT1L . Modifications like H2BK43 di-methylation could potentially alter these interaction surfaces, influencing the recruitment or activity of chromatin regulators.

The structural impact of H2B modifications extends beyond the individual nucleosome to affect higher-order chromatin organization. Studies have shown that H2B ubiquitylation can influence internucleosomal interactions and chromatin condensation by modifying both global and local nucleosome structures . While H2BK120 ubiquitylation appears to have minimal impact on these properties, modifications near the DNA entry/exit sites (like H2BK34 ubiquitylation) can significantly alter chromatin compaction . These findings suggest that the specific position of a modification within the nucleosome structure largely determines its impact on chromatin organization. H2BK43 di-methylation may similarly influence chromatin compaction depending on its positioning relative to internucleosomal contact points. Understanding these structural consequences is essential for interpreting the functional significance of H2BK43 di-methylation in gene regulation and other chromatin-dependent processes.

What are the known trans-histone pathways involving H2B modifications?

Trans-histone pathways represent critical regulatory mechanisms where modifications on one histone influence modifications on another, creating interconnected epigenetic networks. The most well-characterized trans-histone pathway involving H2B is the dependence of H3K79 methylation on H2B ubiquitylation . Research has demonstrated that H2B ubiquitylation at lysine 123 (in yeast, corresponding to K120 in humans) is required specifically for di- and tri-methylation of H3K79 by the methyltransferase Dot1/DOT1L . Interestingly, H3K79 mono-methylation remains detectable even in the absence of H2B ubiquitylation, suggesting a specific regulatory mechanism targeting higher methylation states . This pathway creates a direct link between the ubiquitylation machinery targeting H2B and the methylation events on H3, coordinating these distinct modifications to regulate chromatin states and transcriptional outcomes.

The mechanistic basis for this trans-histone regulation involves direct interaction between DOT1L and ubiquitylated H2B. Structural studies have revealed that DOT1L contains a ubiquitin-binding domain that recognizes the ubiquitin moiety on H2B, positioning the catalytic domain of DOT1L precisely above H3K79 . Additional interactions between DOT1L and the nucleosome surface, particularly with the acidic patch formed by H2A-H2B and the C-terminal helix of H2B, further stabilize this complex . These multiple contact points create a specific recognition interface that enables precise positioning of the methyltransferase active site relative to its target residue on H3. Mutations disrupting these interfaces severely impair the histone methyltransferase activity of DOT1L, highlighting their functional importance .

Beyond the H2B ubiquitylation-H3K79 methylation axis, research has identified additional trans-histone pathways involving H2B and other histones. The same H2B ubiquitylation event that regulates H3K79 methylation also influences H3K4 methylation, creating parallel regulatory pathways affecting distinct histone modifications . More recently, studies have identified a trans-histone pathway specific to H3K79 methylation that depends not on another histone modification but on a charged sequence of amino acids in the histone H4 N-terminal tail . This pathway demonstrates that trans-histone regulation can occur through direct histone-histone interactions rather than requiring intermediate modifications. While specific trans-histone pathways involving H2BK43 di-methylation remain to be fully characterized, these established mechanisms provide models for understanding how this modification might participate in broader epigenetic regulatory networks.

How do you troubleshoot non-specific binding when using Di-Methyl-Histone H2B (Lys43) Antibody?

Non-specific binding represents a common challenge when working with histone modification antibodies, including the Di-Methyl-Histone H2B (Lys43) Antibody. The high conservation of histone proteins and the presence of multiple similar modifications can contribute to cross-reactivity issues that complicate data interpretation . A systematic troubleshooting approach begins with antibody validation using peptide competition assays, where the antibody is pre-incubated with excess synthetic peptides containing the H2BK43me2 modification before application to samples. A significant reduction in signal indicates specificity for the target epitope, while persistent signal suggests non-specific binding. Additionally, researchers should test the antibody on samples from cells where the responsible methyltransferase has been knocked out or knocked down, which should eliminate the specific signal while non-specific binding would remain.

Optimization of blocking conditions represents another critical step in reducing non-specific binding. Standard blocking agents like BSA or non-fat dry milk may not be optimal for all applications with histone modification antibodies. Testing alternative blocking agents such as fish gelatin, casein, or commercial blocking solutions specifically designed for epigenetic applications can significantly improve signal-to-noise ratios. The blocking time and temperature should also be optimized, with longer blocking periods (2-3 hours at room temperature or overnight at 4°C) potentially reducing non-specific interactions. For Western blotting applications, increasing the stringency of wash steps by adding higher concentrations of detergents (0.1-0.3% Tween-20 or 0.1% SDS) to wash buffers can help eliminate non-specific binding without compromising the specific signal.

Technical adjustments to antibody incubation conditions can further improve specificity. Diluting the Di-Methyl-Histone H2B (Lys43) Antibody in solutions containing competing proteins or peptides that bind to common non-specific interaction sites can reduce background. For applications like ChIP, the addition of salmon sperm DNA or other non-specific competitors can reduce binding to repetitive or highly abundant genomic regions. Temperature optimization is also important, as some non-specific interactions are temperature-dependent, with 4°C incubations sometimes providing higher specificity than room temperature incubations. Finally, researchers should consider cross-adsorption of the antibody against related histone modifications or testing alternative antibody clones from different manufacturers, as polyclonal antibodies can vary in specificity between batches .

What is the optimal sample preparation protocol for detecting H2BK43me2 in Western blotting?

Effective detection of H2B lysine 43 di-methylation by Western blotting requires careful sample preparation to preserve the modification and ensure optimal antibody recognition. Histone extraction represents the critical first step, with acid extraction methods being particularly effective for enriching histone proteins . A standard protocol involves cell lysis in a buffer containing 0.2M H2SO4 or 0.25M HCl, followed by TCA precipitation of the acid-soluble fraction containing histones. This approach effectively separates histones from other cellular proteins while preserving most post-translational modifications. Alternative extraction methods using high-salt buffers (containing 420mM NaCl) can also be effective and may better preserve certain labile modifications. Researchers should include phosphatase and deacetylase inhibitors (such as sodium butyrate, TSA, or nicotinamide) in all buffers to prevent loss of modifications during extraction.

The electrophoresis and transfer conditions significantly impact the detection of histone modifications. SDS-PAGE using high percentage gels (15-18%) provides optimal resolution of the relatively small histone proteins (~14-18 kDa). Specialized gel systems designed specifically for histone analysis, such as Triton-Acid-Urea (TAU) gels, can provide enhanced separation of differently modified histone forms. For transfer to membranes, PVDF is generally preferred over nitrocellulose for histone applications due to its stronger protein binding capacity and compatibility with subsequent stripping and reprobing. Transfer conditions should be optimized, with wet transfer at lower voltages (30V) overnight at 4°C often providing better results than rapid transfer protocols. The addition of SDS (0.1%) to the transfer buffer can improve the transfer efficiency of basic proteins like histones, though this should be balanced against potential interference with antibody binding.

Blocking and antibody incubation represent the final critical steps for specific detection. For H2BK43me2 detection, a recommended starting dilution for the antibody is 1:500 to 1:1000 in blocking buffer, though this should be optimized for each specific antibody preparation . The dilution of Di-Methyl-Histone H2B (Lys43) Antibody should strike a balance between sufficient signal strength and minimal background. Extended incubation times (overnight at 4°C) often provide better results than shorter incubations at room temperature. For visualization, both chemiluminescence and fluorescence-based detection systems can be effective, with the latter offering advantages for quantitative analysis. Researchers should always include appropriate controls, such as recombinant histones with defined modification states or samples from cells treated with methyltransferase inhibitors, to validate the specificity of the detected signals.

What technical approaches can validate the specificity of Di-Methyl-Histone H2B (Lys43) Antibody?

Validating antibody specificity is essential for generating reliable data on histone modifications, particularly for less-characterized marks like H2BK43me2. Peptide competition assays represent a fundamental validation approach, where the antibody is pre-incubated with excess synthetic peptides containing the H2BK43me2 modification before application to samples . A significant reduction in signal upon peptide competition indicates specificity for the target epitope. This approach can be extended by comparing competition with peptides containing different methylation states (unmethylated, mono-methylated, tri-methylated) at the same residue, which can reveal potential cross-reactivity with related modifications. Additionally, competition with peptides containing methylation at different lysine residues can identify cross-reactivity with other methylation sites on H2B or other histones.

Genetic and pharmacological approaches provide powerful complementary validation strategies. Cells in which the responsible methyltransferase has been knocked out, knocked down, or inhibited should show reduced or absent H2BK43me2 signal in immunoblotting or immunofluorescence experiments . Similarly, overexpression of this enzyme would be expected to increase the signal if the antibody is specific. While the methyltransferase specifically responsible for H2BK43 di-methylation may not be definitively established yet, researchers can leverage knowledge of related histone methyltransferases as a starting point. For example, DOT1L inhibitors could be used to determine whether this enzyme, known to methylate H3K79, might also influence H2BK43 methylation through direct or indirect mechanisms . The use of histone demethylase overexpression or inhibition systems provides additional validation opportunities by manipulating the removal of methyl groups.

Mass spectrometry-based approaches offer the gold standard for validating histone modification antibodies. Comparing antibody-based detection with quantitative mass spectrometry analysis of histone modifications can confirm the specificity of the antibody and potentially identify unexpected cross-reactivities . Techniques like multiple reaction monitoring (MRM) or parallel reaction monitoring (PRM) mass spectrometry can provide absolute quantification of specific histone modifications, creating a reference standard against which antibody-based measurements can be compared. This approach is particularly valuable for modifications like H2BK43me2 where limited characterization might leave questions about antibody specificity. Additionally, the combination of ChIP with mass spectrometry (ChIP-MS) can identify proteins associated with H2BK43me2-containing chromatin regions, potentially revealing readers of this modification and providing further confirmation of antibody specificity through the detection of known or predicted interaction partners.

What are the emerging research directions involving H2BK43 di-methylation?

Research on histone H2B lysine 43 di-methylation is poised for significant expansion as interest in less-characterized histone modifications continues to grow. One emerging direction involves comprehensive mapping of H2BK43me2 distribution across different cell types, developmental stages, and disease states to establish the genomic contexts in which this modification operates . Integration of these maps with other epigenomic data, including other histone modifications, transcription factor binding, and chromatin accessibility, will help position H2BK43me2 within the broader epigenetic landscape. This integrative approach may reveal co-occurrence patterns or mutual exclusivity relationships with other modifications, providing insights into the functional roles of H2BK43me2 in different chromatin states and gene regulatory contexts.

Identification and characterization of the enzymes responsible for writing, reading, and erasing H2BK43 di-methylation represent another crucial research direction. While the specific methyltransferase(s) that establish this modification remain to be definitively identified, candidates might include enzymes related to those that modify other histone lysine residues . The development of CRISPR-based screens targeting known and predicted methyltransferases, combined with antibody-based detection of H2BK43me2, could accelerate the identification of these enzymes. Similarly, identifying proteins that specifically recognize (read) this modification will provide insights into its downstream effects. Approaches like CRISPR screens for factors affecting H2BK43me2-dependent processes, proteomics of isolated chromatin segments (PICh), or protein microarrays probed with modified peptides can help identify these reader proteins. Understanding the dynamics of H2BK43me2 establishment and removal will be essential for determining its role in cellular processes ranging from transcription to DNA repair.

The potential involvement of H2BK43 di-methylation in disease processes represents a particularly promising research direction with therapeutic implications. Dysregulation of histone modifications has been implicated in numerous diseases, particularly cancer, neurodevelopmental disorders, and aging-related conditions . Systematic analysis of H2BK43me2 levels in patient samples could identify correlations with disease states or progression, potentially establishing this modification as a biomarker. If the enzymes regulating H2BK43me2 are identified, they might represent novel therapeutic targets, similar to how inhibitors of other histone-modifying enzymes have entered clinical development . For instance, DOT1L inhibitors targeting H3K79 methylation have shown promise in treating certain leukemias with MLL rearrangements . Development of small molecules or peptides that specifically disrupt interactions involving H2BK43me2 and its reader proteins could provide additional therapeutic strategies for diseases where this modification contributes to pathogenesis.

How can researchers integrate H2BK43me2 data with other epigenomic datasets?

Effective integration of H2BK43me2 data with other epigenomic datasets requires sophisticated computational approaches combined with careful experimental design. Correlation analysis represents a foundational approach, where genome-wide maps of H2BK43me2 distribution can be compared with maps of other histone modifications, DNA methylation, chromatin accessibility, and transcription factor binding . These analyses can identify modifications that co-occur with H2BK43me2 (positive correlation) or appear mutually exclusive (negative correlation), providing insights into the functional relationships between these marks. More advanced machine learning approaches like random forests or deep neural networks can identify complex patterns and relationships that might not be apparent through simple correlation analysis. These approaches can potentially predict the presence of H2BK43me2 based on other epigenetic features or, conversely, predict gene expression or chromatin states based on H2BK43me2 patterns.

Temporal dynamics provide another important dimension for data integration. Synchronizing cells or using inducible systems to trigger epigenetic changes allows researchers to track the establishment, maintenance, and removal of H2BK43me2 relative to other modifications . Time-course experiments following stimuli that induce chromatin remodeling can reveal whether H2BK43me2 appears early in the process, suggesting a role in initiating chromatin changes, or later, suggesting a role in stabilizing or maintaining particular chromatin states. Such temporal analyses can also reveal potential causal relationships between modifications, particularly when combined with interventions that prevent specific modifications. For example, blocking H2B ubiquitylation and observing the effects on subsequent H2BK43me2 deposition could reveal whether these modifications operate in a sequential or independent manner .